Evidence map›Paper›PMID 30877237›Full record

ArticleJournal of medical genetics2019

Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome.

Rachel Pearlman, Sigurdis Haraldsdottir, Albert de la Chapelle, Jon G Jonasson, Sandya Liyanarachchi, Wendy L Frankel, Thorunn Rafnar, Kari Stefansson, Colin C Pritchard, Heather Hampel

Open access · greenAbstract read
In one paragraph

Article in Journal of medical genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Therapeutic targeting of mismatch repair-deficient cancers.Nature reviews. Clinical oncology · 2025
    Review
  5. Article
  6. Article
  7. Clinicopathological characteristics of Lynch-like syndrome.International journal of clinical oncology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Development and evaluation of INTFrontiers in oncology · 2023
    Article
  18. Article
  19. Cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency.Genetics in medicine : official journal of the American College of Medical Genetics · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Rachel Pearlman *Internal Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.ORCID 0000-0002-9293-5860
Sigurdis Haraldsdottir *Internal Medicine, Stanford University, Stanford, California, USA.
Albert de la ChapelleCancer Biology and Genetics, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Jon G JonassonPathology, Landspitali-National University Hospital, Reykjavik, Iceland.
Sandya LiyanarachchiCancer Biology and Genetics, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Wendy L FrankelPathology, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
Thorunn RafnardeCODE Genetics, Reykjavik, Iceland.
Kari StefanssondeCODE Genetics, Reykjavik, Iceland.
Colin C PritchardLaboratory Medicine, University of Washington, Seattle, Washington, USA.
Heather HampelInternal Medicine, Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
The Ohio State University Wexner Medical Center · USdeCODE Genetics (Iceland) · ISStanford University · USUniversity of Iceland · ISUniversity of Washington · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

backgroundPatients with colorectal cancer (CRC) with mismatch repair-deficient (dMMR) tumours without

methodsWe included patients with CRC from Ohio 2013-2016 and Iceland 2000-2009. All had microsatellite instability testing and/or immunohistochemistry (IHC) of MMR proteins, and

resultsOf the 232 and 51 patients with non-methylated dMMR tumours in the Ohio and Iceland cohorts, respectively, 57.8% (n=134) and 45.1% (n=23) had LS, 32.8% (n=76) and 31.4% (n=16) had DS PVs, 6% (n=14) and 9.8% (n=5) were unexplained and 4.3% (n=10) and 13.7% (n=7) had incorrect IHC. Age of diagnosis for DS patients was older than patients with LS (p=3.73×10

conclusionsIndividuals with LS are 15× more likely to meet Amsterdam II criteria and >5× more likely to have multiple cancers as compared with those with DS tumours. Furthermore, isolated loss of MSH6 or PMS2 protein predicts LS.

Indexed as

DNA Mismatch RepairGenetic Predisposition to DiseaseMutationAdultAgedAged, 80 and overBiomarkers, TumorColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisDNA MethylationFemaleGenetic Association StudiesGenetic TestingGerm-Line MutationHumansMaleBiomarkers, TumorDNA repair systemLynch-like syndromesomatic mutationtumour testing

Identifiers

PMID30877237
PMCPMC6748629
OpenAlexW2922173474

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.